等待开盘 05-20 09:30:00 美东时间
-0.440
-1.71%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36
Shares of space-related companies are trading higher. The industry may be rally...
05-12 03:54
UBS analyst Gavin Parsons upgrades StandardAero (NYSE:SARO) from Neutral to Buy and lowers the price target from $35 to $34.
05-11 20:58
华盛资讯5月8日讯,StandardAero, Inc.公布2026财年Q1业绩,公司Q1营收16.27亿美元,同比增长13.3%,归母净利润0.80亿美元,同比增长27.0%。
05-08 07:20
StandardAero (NYSE:SARO) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.28 by 17.86 percent. This is a 13.79 percent increase over earnings of $0.29 per share from the same
05-08 05:25
StandardAero (NYSE:SARO), a leading independent pure-play provider of aerospace engine aftermarket services including engine maintenance, repair and overhaul (MRO) and engine component repair, today announced it has
05-08 04:58
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
RBC Capital analyst Ken Herbert maintains StandardAero (NYSE:SARO) with a Outperform and lowers the price target from $37 to $34.
05-02 00:09
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27